English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

MIP technology has successfully produced quantitative HER2 copy number (HER2CN) data. Studies have shown high concordance between this emerging technology and conventional methods such as fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC). OncoScan, the device behind MIP technology, appraises tumor percentage in the form of percent aberrant cells (%AC). However, inability to assess tumor heterogeneity, extensive stroma within the tumor, and prominent in situ …

american journal of clinical pathology

Assessing Tumor Percentage: A Possible Solution in Evaluating HER2 Copy Number (HER2CN) Data Generated by Molecular Inversion Probe (MIP) Technology on Formalin-Fixed Paraffin-Embedded (FFPE) Sections of Breast Cancer (BC) With Low Tumor Cellularity